Kamada Pharmaceuticals - Company Profile
Powered by
All the data and insights you need on Kamada Pharmaceuticals in one report.
- Save hours of research time and resources with
our up-to-date Kamada Pharmaceuticals Strategy Report
- Understand Kamada Pharmaceuticals position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Kamada Pharmaceuticals (Kamada) develops and markets plasma-derived protein therapeutics for the treatment of lung diseases, asthma, Japanese encephalitis, hemophilia, and orphan diseases. Competitive landscape, R&D focus, and proprietary product segment performance are its strengths even as a decline in business performance of distribution segment is a major cause of concern for the company. Kamada could benefit from strategic acquisitions, agreements and the market potential of Hemophilia A and B. However, high competition, technological advancements, and government regulations could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer